Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.

Oncotarget - 27 Sept 2016

Zhang Shumeng, Yan Bing, Zheng Jing, Zhao Jing, Zhou Jianying

Abstract excerpt

Lung cancer with mediastinal lymph node metastasis is more likely to develop recurrence and metastasis after complete resection and targeted therapy is a promising treatment strategy. We performed amplification refractory mutation system (ARMS) fluorescence quantitative PCR to detect the gene status of EGFR, ALK, ROS1 and RET in resected samples from 280 patients who were confirmed to have primary lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Differentiation

Share to Cohort Studies

Share to Genotype

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 27563816
DOI: 10.18632/oncotarget.11494
PMCID: PMC5325401

Genes

ALK
EGFR
RET
ROS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.PMID 27563816Read ↗

High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma.Semantic proximity Read ↗

Clinical characteristics of patients with non-small cell lung cancers harboring anaplastic lymphoma kinase rearrangements and primary lung adenocarcinoma harboring epidermal growth factor receptor mutations.Semantic proximity Read ↗

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China.Semantic proximity Read ↗

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients.Semantic proximity Read ↗

Analysis of Multigene Mutations in Lung Adenocarcinoma in Zunyi.Semantic proximity Read ↗

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusionsSemantic proximity Read ↗

Analysis of lung biopsies using the 2015 WHO criteria and detection of sensitizing mutations--a single-institution experience of 5032 cases.Semantic proximity Read ↗

Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCRSemantic proximity Read ↗

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patientsSemantic proximity Read ↗

Evaluation of ROS1 expression and rearrangements in a large cohort of early- stage lung cancerSemantic proximity Read ↗

Concurrent classic driver oncogenes mutation with ROS1 rearrangement predicts superior clinical outcome in NSCLC patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.